Dr. Goetz H. Kloecker
Dr. Goetz H. Kloecker is a medical oncologist at the University of Louisville James Graham Brown Cancer Center in Louisville, Kentucky. He is the director of the center's thoracic oncology clinic, as well as a professor of medicine at the University of Louisville. In addition to teaching, Dr. Kloecker is the director of the medical oncology/hematology fellowship program at the school.
Dr. Kloecker has over 20 years of experience in diagnosing and treating lung cancer and other lung conditions like pleural mesothelioma. He has authored and co-authored dozens of studies in prestigious scientific and medical journals, like the American Journal of Clinical Oncology. Many of the clinical trials he's participated in have focused on tumor genetics, immunosuppressive proteins and new treatment options like stereotactic radiation therapy.
Main Specialty: Medical Oncology
Other Interests & Specialties: Hematology, thoracic cancer, general oncology and medical oncology.
Certifications, Awards & Accolades: American Board of Internal Medicine Certification in Hematology, American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Certification in Medical Oncology, member of the American Medical Association, member of American Society of Clinical Oncology (ASCO), member of the Kentucky Medical Association, member of the European Society of Oncology, Regional Top Doctor
Education & Experience:
- Residency for Internal Medicine at the University of Louisville
- Fellowship for Hematology/Oncology at the University of Louisville
- Medical Degree from the Technical University of Munich
Treatment and outcomes of non-small-cell lung cancer patients with high comorbidity. Cancer Management and Research. January 2018;10:167-175. doi: 10.2147/CMAR.S151935
The role of alectinib in the treatment of advanced ALK-rearranged non-small-cell lung cancer. Expert Review of Anticancer Therapy. December 2016;16(12):1227-1233. doi: 10.1080/14737140.2016.1249857
Plasma thermogram profiling: A novel biomarker for lung cancer. Biomarker Research. January 2013;1: 4. doi: 10.1186/2050-7771-1-4